Sentynl is a pharmaceutical company that develops and commercializes pain care therapeutics... Read more
Sentynl is a pharmaceutical company that develops and commercializes pain care therapeutics... Read more
News
Mar 17, 2026
Pharmaceutical Business Review
Sentynl Therapeutics: Sentynl and PRG partner for Progerinin licence
Mar 16, 2026
Contract Pharma
Sentynl Therapeutics: Sentynl to License Investigational Molecule from PRG S&T for Progeria Treatment
Jan 13, 2026
Business Standard
Sentynl Therapeutics: Sentynl (Zydus Group) receives USFDA approval for ZYCUBO
Jan 13, 2026
FiercePharma
Sentynl Therapeutics: FDA blesses Sentynl and Cyprium's Zycubo as 1st treatment for Menkes disease.
Jan 13, 2026
BioSpace
Sentynl Therapeutics: Sentynl, Fortress Bounce Back With FDA Approval for Rare Pediatric Disease
Dec 16, 2025
Indian Pharma Post
Sentynl Therapeutics: FDA accepts Sentynl Therapeutics CUTX-101 NDA resubmission
Dec 10, 2025
FinanzNachrichten
Sentynl Therapeutics: myTomorrows; Zydus: Sentynl Selects myTomorrows to Lead Managed Access Program
Oct 01, 2025
PR Newswire
Press Release: Sentynl Therapeutics : Sentynl Therapeutics updates on its NDA for CUTX-101
Oct 01, 2025
BioSpace
Sentynl Therapeutics: Fortress, Sentynl Fail To Secure FDA Nod in Rare Pediatric Disease
Sep 25, 2025
Manufacturing Chemist
Sentynl Therapeutics: Er-Kim partners with Sentynl Therapeutics to expand access to ultra-rare disease treatments Nulibry and Zokinvy
Sentynl Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10